An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

In this section: Vaccines

SHINGRIX

STN: 125614
Proper Name: Zoster Vaccine Recombinant, Adjuvanted
Tradename: SHINGRIX
Manufacturer: GlaxoSmithKline Biologicals
Indication:

SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles):
- in adults aged 50 years and older.
- in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy.

Product Information

Package Insert - SHINGRIX
Demographic Subgroup Information - Zoster Vaccine Recombinant, Adjuvanted (SHINGRIX)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.

Supporting Documents

Top